Calorie restriction is shown to have a negative effect, hastening the progression of ALS. Research has been done on using RNAi in the treatment of ALS, and Cytrx's orally-administered drug Arimoclomol is currently in clinical evaluation as a therapeutic treatment for ALS. Insulin-like growth factor 1 has also been studied as treatment for ALS.
Amyotrophic lateral sclerosis future or investigational therapies
Multiple sclerosis alternative therapies
Amyotrophic lateral sclerosis medical therapy
Multiple sclerosis medical therapy
Parkinson's disease medical therapy
Multiple sclerosis primary prevention
Multiple sclerosis tertiary prevention
Myasthenia gravis medical therapy